• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常人类淋巴细胞增殖过程中bcl-2原癌基因表达的调控。

Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.

作者信息

Reed J C, Tsujimoto Y, Alpers J D, Croce C M, Nowell P C

出版信息

Science. 1987 Jun 5;236(4806):1295-9. doi: 10.1126/science.3495884.

DOI:10.1126/science.3495884
PMID:3495884
Abstract

The bcl-2 and c-myc proto-oncogenes are brought into juxtaposition with the immunoglobulin heavy chain locus in particular B-cell lymphomas, resulting in high levels of constitutive accumulation of their messenger RNAs. Precisely how the products of the bcl-2 and c-myc genes contribute to tumorigenesis is unknown, but observations that c-myc expression is rapidly induced in nonneoplastic lymphocytes upon stimulation of proliferation raise the possibility that this proto-oncogene is involved in the control of normal cellular growth. In addition to c-myc, the bcl-2 proto-oncogene also was expressed in normal human B and T lymphocytes after stimulation with appropriate mitogens. Comparison of the regulation of the expression of these proto-oncogenes demonstrated marked differences and provided evidence that, in contrast to c-myc, levels of bcl-2 messenger RNA are regulated primarily through transcriptional mechanisms.

摘要

在某些特定的B细胞淋巴瘤中,bcl-2和c-myc原癌基因与免疫球蛋白重链基因座并列,导致其信使RNA高水平的组成性积累。bcl-2和c-myc基因的产物究竟如何促进肿瘤发生尚不清楚,但有观察表明,在非肿瘤性淋巴细胞受到增殖刺激后,c-myc表达会迅速被诱导,这增加了这种原癌基因参与正常细胞生长调控的可能性。除了c-myc,bcl-2原癌基因在用适当的促细胞分裂剂刺激后的正常人B淋巴细胞和T淋巴细胞中也有表达。对这些原癌基因表达调控的比较显示出显著差异,并提供了证据,与c-myc相反,bcl-2信使RNA的水平主要通过转录机制进行调控。

相似文献

1
Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.正常人类淋巴细胞增殖过程中bcl-2原癌基因表达的调控。
Science. 1987 Jun 5;236(4806):1295-9. doi: 10.1126/science.3495884.
2
Expression of c-myc proto-oncogene in normal human lymphocytes. Regulation by transcriptional and posttranscriptional mechanisms.c-myc原癌基因在正常人淋巴细胞中的表达。转录和转录后机制的调控。
J Clin Invest. 1987 Jul;80(1):101-6. doi: 10.1172/JCI113034.
3
Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.原癌基因在凝集素刺激的正常人淋巴细胞有丝分裂过程中的顺序表达。
Proc Natl Acad Sci U S A. 1986 Jun;83(11):3982-6. doi: 10.1073/pnas.83.11.3982.
4
Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.小鼠肝脏再生过程中以及蛋白质合成受抑制后jun、c-fos和c-myc原癌基因的差异调节与表达
Oncogene. 1990 Oct;5(10):1511-9.
5
Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.克隆化T淋巴细胞中原癌基因的表达:有丝分裂原和生长因子诱导不同的表达模式。
Oncogene. 1987 May;1(2):223-8.
6
Cellular oncogenes and lymphocyte activation.细胞癌基因与淋巴细胞激活
Behring Inst Mitt. 1987 Jun(81):110-9.
7
Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2.白细胞介素2介导的基因转录及原癌基因bcl-2的异常表达对细胞毒性T细胞系中细胞凋亡的抑制作用。
Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2189-93. doi: 10.1073/pnas.90.6.2189.
8
Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens.小鼠淋巴细胞中细胞癌基因表达的动力学。I. 多种有丝分裂原诱导的T淋巴细胞中c-myc和c-ras-Ha的表达
Eur J Immunol. 1986 Mar;16(3):312-6. doi: 10.1002/eji.1830160319.
9
Mitogenic activation of normal T cells leads to increased initiation of transcription in the c-myc locus.
J Biol Chem. 1988 Apr 5;263(10):4828-31.
10
Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.核原癌基因在由促有丝分裂和非促有丝分裂的T3和T11激活信号触发的T细胞中的差异表达。
J Immunol. 1987 Oct 1;139(7):2143-8.

引用本文的文献

1
The BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation.BCL2 抑制剂 venetoclax 通过树突状细胞激活发挥抗癌作用。
Cell Death Differ. 2023 Dec;30(12):2447-2451. doi: 10.1038/s41418-023-01232-y. Epub 2023 Oct 16.
2
Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies.美国食品药品监督管理局(FDA)和/或欧洲药品管理局(EMA)批准的用于治疗血液系统恶性肿瘤的靶向疗法的副作用概述。
J Clin Med. 2020 Sep 8;9(9):2903. doi: 10.3390/jcm9092903.
3
Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo.
在体外感染的R5嗜性和X4嗜性HIV-1产生的淋巴组织细胞中,出现了不同模式的Bcl-2表达。
AIDS Res Hum Retroviruses. 2015 Mar;31(3):298-304. doi: 10.1089/aid.2014.0155. Epub 2014 Oct 29.
4
In vitro antitumor mechanism of a novel cyclin-dependent kinase inhibitor CDKI-83.新型细胞周期蛋白依赖性激酶抑制剂 CDKI-83 的体外抗肿瘤机制。
Invest New Drugs. 2012 Jun;30(3):889-97. doi: 10.1007/s10637-011-9641-5. Epub 2011 Feb 18.
5
Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation.Ras 激活 Erk 恢复受损的 BCR 信号传递,并挽救未成熟 B 细胞分化。
J Exp Med. 2010 Mar 15;207(3):607-21. doi: 10.1084/jem.20091673. Epub 2010 Feb 22.
6
Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus.用减毒的缺失N1L痘苗病毒诱导强大的肺内CD8 T细胞应答及产生保护作用。
PLoS One. 2008 Oct 2;3(10):e3323. doi: 10.1371/journal.pone.0003323.
7
Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia.介导程序性细胞死亡的基因:结直肠肿瘤中bcl-2、c-myc和p53表达的免疫组织化学研究
Clin Mol Pathol. 1996 Jun;49(3):M151-8. doi: 10.1136/mp.49.3.m151.
8
Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death.黄酮哌醇对转录的抑制作用:慢性淋巴细胞白血病细胞死亡机制
Blood. 2005 Oct 1;106(7):2513-9. doi: 10.1182/blood-2005-04-1678. Epub 2005 Jun 21.
9
Light induced apoptosis is accelerated in transgenic retina overexpressing human EAT/mcl-1, an anti-apoptotic bcl-2 related gene.在过表达人EAT/mcl-1(一种抗凋亡的bcl-2相关基因)的转基因视网膜中,光诱导的细胞凋亡加速。
Br J Ophthalmol. 2001 Oct;85(10):1237-43. doi: 10.1136/bjo.85.10.1237.
10
Transcriptional reprogramming during T helper cell differentiation.辅助性T细胞分化过程中的转录重编程。
Immunol Res. 2001;23(2-3):193-204. doi: 10.1385/IR:23:2-3:193.